Disruptive Innovation Grants in Cancer Research – Letter of Intent

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: inquire with unit

Memorial Deadline: RIS Review not required for LOI

External Deadline: Thursday 21st, March 2024


Description

The Lotte & John Hecht Memorial Foundation in partnership with the Canadian Cancer Society are excited to announce a pre-launch of a new funding opportunity – “Disruptive Innovation Grants in Cancer Research”. These grants will provide a unique opportunity for researchers in cancer, or any other field of discipline, to test out their novel ideas for potentially game-changing impact in cancer prevention, detection, or treatment. Disruptive Innovation grants will be bold, high risk/high reward, early-stage projects for which preliminary data is not required. Projects will be rated on their novelty, feasibility, and potential impact in the cancer field. Examples of the kinds of projects we are seeking would include the adaptation of breakthroughs in other health conditions, such as cardiovascular, metabolic, and infectious diseases to the cancer field, or the harnessing of technologies from fields such as AI, robotics, engineering, chemistry, biology and ecology, or the opportunity to pursue serendipitous observations not supported by existing funding. These grants are not intended to support research that represents incremental activities in a program of work or an expansion of previous work, but rather provide truly novel insights and directions for future larger grants that will serve as “game-changers” in the way we approach cancer, disrupting existing methods and displacing the status quo.

Up to $4M is available for this funding opportunity, enough to fund up to 16 projects to be awarded $250k over two years. Funding can be applied to generating pilot data for a new and exciting idea, establishing, and developing new collaborations where appropriate, testing a new technology/intervention, or using an existing technology/intervention in an innovative way.

For more details about the program, please, visit https://cancer.ca/en/research/for-researchers/funding-opportunities/pre-announcement-disruptive-innovation-grants

Program Launch:  Mid-January 2024
Letter of Intent due date:  March 21st, 2024
Full application due date:  August 1st, 2024

Funding Sources

Canadian Cancer Society
Hecht Foundation



This opportunity was posted by: RGCS

Last modified: January 31, 2024